AstraZeneca plans its largest manufacturing investment in Virginia, reported from Cambridge.
2 reports, 2 independent
Updated Jul 29
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca plans its largest manufacturing investment in Virginia, reported from Cambridge.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- AstraZeneca is investing $4.5 billion in a new manufacturing campus near Charlottesville, Virginia.Sub-event
AstraZeneca announced plans for its largest manufacturing investment in Virginia.1 source
Keep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
Virginia
human settlement in Argentina
- Abigail Spanberger and other Virginia officials are discussing delays and moving the start date of a project rollout.
- Hanmi Financial Corporation, the parent company of Hanmi Bank, operates across multiple states, including offices in Los Angeles, loan production offices in Texas, and loan centers in Virginia.
Related events
Coverage
Newest first; wire copies grouped- Business WireAstraZeneca results: H1 and Q2 2025 Strong growth momentum continues with excellent R&D pipeline delivery in the year-to-date CAMBRIDGE, England, July 29, 2025--(BUSINESS WIRE)--AstraZeneca: Revenue
- Simply Wall St.AstraZeneca (LSE:AZN) Commits US$50 Billion For US Expansion By 2030 AstraZeneca recently announced plans to invest $50 billion in the U.S. by 2030, including the development of a major manufacturing